Gazyva - Google News

Real-World Data Highlight Feasibility of Venetoclax Plus Obinutuzumab In First-Line CLL With Comorbidities - OncLive

about 1 month ago

Real-World Data Highlight Feasibility of Venetoclax Plus Obinutuzumab In First-Line CLL With...

Obinutuzumab may meet demand for more ‘potent’ options in lupus nephritis - Healio

about 2 months ago

Obinutuzumab may meet demand for more ‘potent’ options in lupus nephritis  Healio

Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s - GlobeNewswire

2 months ago

Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s  GlobeNewswire

Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports - Yahoo Finance

2 months ago

Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as...

US expands Roche, AbbVie's Venclexta for use in combination with Gazyva for previously untreated CLL - FirstWord Pharma

3 months ago

US expands Roche, AbbVie's Venclexta for use in combination with Gazyva for...

Combination Therapies for CLL - MedPage Today

3 months ago

Combination Therapies for CLL  MedPage Today

Exploring BTK Inhibitors for Patients With CLL and Del(17p) Mutations - Targeted Oncology

4 months ago

Exploring BTK Inhibitors for Patients With CLL and Del(17p) Mutations  Targeted Oncology

AstraZeneca's Calquence combo wins first-line CLL approval in EU - FirstWord Pharma

4 months ago

Acalabrutinib-Based Regimens Receive European Approval in Frontline CLL - OncLive

4 months ago

Roche's Gazyva meets main goal in Phase III lymphoma study - FirstWord Pharma

4 months ago

B-cell targeting therapies may break ‘evolving cycle’ of lupus - Healio

5 months ago

Specialists Eye Gazyva as a New Option for Lupus Nephritis, - GlobeNewswire

5 months ago